Biomarkers and Precision Oncology Forum (BPOF) shared on LinkedIn:
“The future of Breast Cancer care isn’t coming — it’s already here.
Precision oncology is rewriting the rules faster than any field in medicine. New trials. New targets. New standards — almost monthly. The question every oncologist is quietly asking: ‘Am I keeping up?’
At BPOF 2026, our Featured Speaker Dr. Nitesh Rohatgi from Fortis Healthcare Institute takes the stage with a session built to answer exactly that with the topic: ‘Precision Oncology Trials in Breast Cancer: This is the Future!’
30 July 2026, 11:25 – 11:45 HRS (SGT)
Academia, Singapore
Walk away with the trial insights shaping tomorrow’s practice — plus 4 CME and 4 CPE points (accredited by SMC and SNB) to make every minute count.
Don’t just hear about the future. Move the needle with the people building it.
Seats are limited — and they fill fast. Register now. Use code BPOFDISC20 for 20% off.”
You can also read:
Gedatolisib Enters ER+ Breast Cancer Care, But the Real Question Is How to Use It
